Hillenbrand - Upgrades & Downgrades
NEW YORK (
) -TheStreet Ratings' stock model downgraded
Hillenbrand Inc
(HI) - Get Report
to 'Hold from 'Buy'. Net income at this $1.3 billion market cap, funeral services & casket supplier plunged by 47.6%, to $13.3 million in the third quarter over the same quarter last year.
TheStreet Ratings released rating changes on 29 U.S. common stocks for November 4, 2010. In total, 11 stocks were downgraded and 18 stocks have been upgraded by our stock model.
In the third quarter, gross revenue at Hillenbrand rose by 29.7% to $205.8 million. Learn more about Hillenbrand:
Company Profile
,
Income Statement
,
Balance Sheet
,
Stock Ratios
,
Analyst Ratings
.
$4.3 billion market cap, pharmaceutical company,
Valeant Pharmaceuticals International
(VRX)
was downgraded to 'Hold' from 'Buy'. In third quarter results for Valeant Pharmaceuticals International gross revenue shrank 2.1% to $208 million while the company's bottom line changed to a loss of $207.9 million from a gain of $40.4 million in the year earlier quarter. Learn more about Valeant Pharmaceuticals International:
Company Profile
,
Income Statement
,
Balance Sheet
,
Stock Ratios
,
Analyst Ratings
.
-- Reported by Kevin Baker in Jupiter, Fla.
For additional
check out our Ratings Research Center.
Kevin Baker became the senior financial analyst for TheStreet Ratings upon the August 2006 acquisition of Weiss Ratings by TheStreet.com, covering mutual funds. He joined the Weiss Group in 1997 as a banking and brokerage analyst. In 1999, he created the Weiss Group's first ratings to gauge the level of risk in U.S. equities. Baker received a B.S. degree in management from Rensselaer Polytechnic Institute and an M.B.A. with a finance specialization from Nova Southeastern University.
